For one health-care venture capitalist, the search for ‘another miracle’ turns personal

For one health-care venture capitalist, the search for ‘another miracle’ turns personal

It’s been less than a year since Jonathan Silverstein, a venture capitalist at health-care fund OrbiMed, received the diagnosis that changed everything. Parkinson’s disease at age 49. A potentially more aggressive, inherited form, driven by a mutation in a gene called GBA. It affects up to 10 percent of Americans with Parkinson’s, and — as for other forms of the neurodegenerative disease — there is no cure, or even treatments that slow its course. In recent months, Silverstein and his wife, Natalie, set up the Silverstein Foundation, raised $6 million…

Read More